A Study of Intermittent Doses of CERC-301 in MDD

Clinical trial NCT02459236 · COMPLETED

Trial details

NCT number: NCT02459236
Sponsor: Avalo Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2015-06-01
Primary completion: 2016-09-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.